Due to CD8+ T cells from B-cell Erbin-deficient mice were not genetically modified, and thus the effect of CD8+ T cells isolated from B-cell Erbin-deficient mice to kill tumor cells was activated in vivo by other cell subpopulations, particularly Erbin-deficient B cells. This evidence concerns the gene ERBIN and neoplasm.